Table 1

Study assessment schedule

Control armIntervention arm
ProcedureSurgeryEligibility/ dischargeOutpatient appointmentPre-CRCR sessions
(8–16 sessions over 8 weeks)
Post-CRFinal follow-up visitOutpatient appointmentPre-CRCR sessions
(8–16 sessions over 8 weeks)
Post-CRFinal follow-up visit
Week −1Week 0Week 6# Week 8Week 16Week 26Week 3Week 4Week 12Week 26
Surgery·*
Screening for eligibility·
Consent·
Baseline data collection·
Randomisation·
Clinical examination·*·*··*·
Cardiopulmonary exercise test·†·†·†
Incremental shuttle walk test······
EQ-5D-5L·······
CR·*·*·*·*
Vital signs—heart rate, blood pressure, oxygen saturation·*·*·*·*·*
Participant interviews‡····
Session attendance··
Session content··
Participant diary···
Resource use questions······
Adverse event monitoring·*····*···
  • *Part of normal patient pathway.

  • †For only 25 participants in each group from Hull site.

  • ‡For a purposive sample of up to 10 patients in each treatment arm.

  • CR, cardiac rehabilitation; EQ-5D-5L, EuroQol-5 dimensions-5 levels.